MD, MPH, FAHA, FACC
Wayne State University
Detroit, MI, USA
Ileana L. Piña is a heart failure and cardiac transplantation cardiologist expert. She serves as an advisor/consultant to the FDA’s Center for Devices and Radiological Health. In January 2019, Dr. Piña joined the faculty of Wayne State University as Professor of Medicine.
In 1999, Dr. Piña joined the faculty of Case Western Reserve University (CWRU) in Cleveland, Ohio, as Professor of Medicine and became the Director of the Heart Failure and Transplantation Section in the Department of Medicine and the Division of Cardiology at University Hospitals of Cleveland. In 2009, she completed a VA Quality Fellowship Program at the Louis Stokes Veterans Administration Medical Center. In January 2010, she earned her master’s degree in Public Health from CWRU. Dr. Piña is American Board of Internal Medicine (ABIM)-certified for heart failure and transplantation.
Dr. Piña is internationally recognised for her research in rehabilitation and recovery of heart failure patients. She is the author of over 200 publications in print and a world-renowned speaker on this subject. Dr. Piña is a member of the American Heart Association (AHA) Get With the Guidelines Scientific Committee and Heart Failure working group, a national spokesperson for Go Red for Women and was on the writing committee of the AHA Guidelines for the prevention of heart disease in women, breast cancer and heart failure, among other publications. She represents the AHA at the Electronic Health Initiative and is on the Leadership Committee of the AHA Quality Council.
Since 1982, Dr. Piña has been an AHA volunteer after she completed her cardiology fellowship in Miami. She currently serves as the immediate past Chair of the Council on Clinical Cardiology of the AHA and is now the Nominating Committee Chair. She is involved in National Institutes of Health Data and Safety Monitoring Board Committees and with the ABIM for the Specialty Exam of Heart Failure/Transplant. She was the recipient of the Wenger Award for Heart Disease in Women in 2017.